This brief document shows the Bureau of Justice Assistance measures for assessment of activities for the years 2021 and 2022, and provides insights into how the Comprehensive Opioid, Stimulant, and Substance Use Program is impacting stakeholders, communities, and individuals throughout the U.S.
In this document, the Bureau of Justice Assistance (BJA) presents its assessment of activities for the years 2021 and 2022, and provides data on several Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) priority areas. The COSSUP funding highlights section summarizes performance data reported by grantees or subgrantees who were active in calendar year (CY) 2021 and 2022. The document provides breakdowns of Naloxone training categories for 2021 and 2022; law enforcement (LE)-led programs; and key COSSUP activities, including diversion and deflection, treatment courts and community supervision, and jail and reentry-based programming. The document also informs of COSSUP’s substance use treatment services, including inpatient, outpatient, partial hospitalization programs 9PHP, mental health treatment, family therapy, and more.
Downloads
Similar Publications
- Prevalence of Fentanyl and Its Analogues in a Court-Ordered Mandatory Drug Testing Population
- Random Forest Processing of Direct Analysis in Real-Time Mass Spectrometric Data Enables Species Identification of Psychoactive Plants From Their Headspace Chemical Signatures
- The Cross-Reactivity of Cannabinoid Analogs (Delta-8-THC, Delta-10-THC and CBD), Their Metabolites and Chiral Carboxy HHC Metabolites in Urine of Six Commercially Available Homogeneous Immunoassays